Taiko Pharmaceutical Co.,Ltd. (TYO:4574)
Japan · Delayed Price · Currency is JPY 296.00
+10.00 (3.50%)
At close: Mar 5, 2026
Taiko Pharmaceutical Market Cap
Taiko Pharmaceutical has a market cap or net worth of 14.87 billion as of March 5, 2026. Its market cap has decreased by -7.68% in one year.
Market Cap
14.87B
Enterprise Value
11.43B
Revenue
6.40B
Ranking
n/a
PE Ratio
16.11
Stock Price
296.00
Market Cap Chart
Since March 18, 2009, Taiko Pharmaceutical's market cap has increased from 10.71B to 14.87B, an increase of 38.82%. That is a compound annual growth rate of 1.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 14.37B | -4.03% |
| Dec 30, 2025 | 14.97B | -9.87% |
| Dec 30, 2024 | 16.61B | 10.16% |
| Dec 29, 2023 | 15.08B | -12.28% |
| Dec 30, 2022 | 17.19B | -52.12% |
| Dec 30, 2021 | 35.91B | -48.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mizuho Medy | 34.74B |
| Fuso Pharmaceutical Industries,Ltd. | 20.15B |
| Pharma Foods International | 16.77B |
| Wakamoto Pharmaceutical | 10.96B |
| Morishita Jintan | 9.40B |
| Solasia Pharma K.K. | 8.35B |
| SymBio Pharmaceuticals | 7.74B |
| WDB coco | 6.40B |